|
Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer |
08/07/2015 |
CIM |
|
Rectal Ozone in the COVID-19 treatment |
05/06/2020 |
CPN |
|
Rectal ozone therapy in high-risk symptomatic SARS-CoV-2 positive patients |
15/07/2021 |
CPN |
|
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations |
22/05/2021 |
CIM |
|
Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III. |
01/10/2020 |
CIM |
|
Safety and immunogenicity of the CIGB 2020. |
14/07/2020 |
CIGB |
|
Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II. |
28/04/2017 |
FINLAY |
|
Safety and pharmacokinetics of CIGB-552 |
22/05/2015 |
CIGB |
|
Safety evaluation of Bacillus clausii AO1125 for its use as a probiotic in humans |
07/08/2023 |
HHA |
|
Safety evaluation of Bacillus coagulans AO1167 for its use as a probiotic in humans |
07/08/2023 |
HHA |
|
Safety of Orally Administered Neutral pH Super Oxidation Electrolyzed Solution |
21/07/2023 |
SSA |
|
Safety with interferon in skin carcinomas (SCIENCE study) |
2013-01-30 |
CIGB |
|
SOBERANA - INTERVENTION |
19/03/2021 |
FINLAY |
|
SOBERANA CENTRO |
23/07/2021 |
FINLAY |
|
SOBERANA PLUS PEDIATRIA |
28/09/2021 |
FINLAY |
|
SOFIA Study |
2011-05-24 |
CIGB |
|
Study on pneunococcal vaccination in the pediatric population from 1 year to 5 years |
03/08/2023 |
FINLAY |
|
Teravac HIV in chronic HIV-1. |
2011-08-10 |
CIGB |
|
THERESA-4 Study |
2011-10-25 |
CIGB |
|
To evaluate the immunogenicity and safety of SOBERANA® 02 and SOBERANA® Plus as booster of immunity against the omicrom variant of SARS-CoV-2, in adult subjects |
19/05/2023 |
FINLAY |
